Joseph Gerard Flanagan net worth and biography

Joseph Flanagan Biography and Net Worth

CEO of R1 RCM

Mr. Flanagan has served as our President and Chief Executive Officer and as a member of our board of directors since May 2016, after having served as our President and Chief Operating Officer since April 2016. Mr. Flanagan joined R1 as Chief Operating Officer in April 2013 after serving as Senior Vice President of worldwide operations and supply chain at Applied Materials, Inc. from February 2010 to April 2013, and previously as President of Nortel Business Services for Nortel Networks. Previously, Mr. Flanagan served most of his career working for General Electric (GE), holding leadership positions in many divisions. Mr. Flanagan also currently serves as a director of GoHealth. We believe Mr. Flanagan’s leadership experience, skill and depth of understanding of our business and market gained from serving as our Chief Operating Officer and Chief Executive Officer, and his experience serving as senior vice president and president of business units at large, publicly held corporations with global operations, qualify him to serve on our board of directors.

What is Joseph Gerard Flanagan's net worth?: The estimated net worth of Joseph Gerard Flanagan is at least $39.82 million as of August 18th, 2022. Mr. Flanagan owns 2,792,221 shares of R1 RCM stock worth more than $39,817,071 as of November 2nd. This net worth approximation does not reflect any other investments that Mr. Flanagan may own. Learn More about Joseph Gerard Flanagan's net worth.
How do I contact Joseph Gerard Flanagan?: The corporate mailing address for Mr. Flanagan and other R1 RCM executives is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. R1 RCM can also be reached via phone at (312) 324-7820 and via email at [email protected]. Learn More on Joseph Gerard Flanagan's contact information.
Has Joseph Gerard Flanagan been buying or selling shares of R1 RCM?: Joseph Gerard Flanagan has not been actively trading shares of R1 RCM within the last three months. Most recently, Joseph Gerard Flanagan sold 200,000 shares of the business's stock in a transaction on Thursday, August 18th. The shares were sold at an average price of $24.98, for a transaction totalling $4,996,000.00. Following the completion of the sale, the chief executive officer now directly owns 2,792,221 shares of the company's stock, valued at $69,749,680.58. Learn More on Joseph Gerard Flanagan's trading history.
Who are R1 RCM's active insiders?: R1 RCM's insider roster includes Richard Evans, Jr. (Insider), Michael Feiner (Director), Joseph Flanagan (CEO), John Henneman, III (Director), Gary Long (Insider), Alex Mandl (Director), Lee Rivas (CEO), and John Sparby (COO). Learn More on R1 RCM's active insiders.
Are insiders buying or selling shares of R1 RCM?: In the last year, insiders at the healthcare provider sold shares 1 times. They sold a total of 10,046 shares worth more than $143,959.18. The most recent insider tranaction occured on March, 7th when President John M Sparby sold 10,046 shares worth more than $143,959.18. Insiders at R1 RCM own 36.8% of the company. Learn More about insider trades at R1 RCM.
Information on this page was last updated on 3/7/2024.

Joseph Gerard Flanagan Insider Trading History at R1 RCM

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/18/2022	Sell	200,000	$24.98	$4,996,000.00	2,792,221
8/16/2022	Sell	200,000	$25.18	$5,036,000.00	2,792,221
11/11/2021	Sell	93,931	$25.60	$2,404,633.60
11/9/2021	Sell	82,920	$25.50	$2,114,460.00
10/13/2021	Sell	30,699	$23.07	$708,225.93
6/1/2021	Sell	500,000	$21.82	$10,910,000.00	2,481,799
3/16/2020	Buy	5,000	$9.12	$45,600.00	1,064,522
8/10/2016	Buy	100,000	$1.56	$156,000.00	1,431,814

Joseph Gerard Flanagan Buying and Selling Activity at R1 RCM

R1 RCM Company Overview

R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah.

Today's Range

Now: $14.26

$14.26

$14.27

50 Day Range

MA: $14.17

$14.04

$14.26

2 Week Range

Now: $14.26

$8.87

$15.12

Volume

1,169,839 shs

Average Volume

3,503,963 shs

Market Capitalization

$6.02 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.85

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.